InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
T+90 hit rate
54%
T+90 mean return
-9.5%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Patel Sanjiv, Chief Executive Officer. Director active across 2 companies, notably Relay Therapeutics, Inc.. Cumulatively, 19 reports have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €2.5m. Activity tracked since 31 December 2021. The latest transaction was disclosed on 30 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations19 total
3,056 shares@ US$6.95Common StockSEC:0001193125-26-298681:0
48,199 shares@ US$19.58Common StockSEC:0001193125-26-298681:1
42,769 shares@ US$2.974.9% of flowCommon StockSEC:0000950170-25-057996:0
140,182 shares@ US$3.8522.7% of flowCommon StockSEC:0000950170-25-020272:0
125,000 shares@ US$4.5223.5% of flowCommon StockSEC:0000950170-25-008451:0
100,000 shares@ US$5.0020.6% of flowCommon StockSEC:0000950170-24-137960:0
50,000 shares@ US$5.0410.1% of flowCommon StockSEC:0000950170-24-087435:0
2,108 shares@ US$5.540.5% of flowCommon StockSEC:0000950170-24-079693:0
762,360 shares0Common StockSEC:0001209191-24-001843:0
1,662 shares@ US$10.684.0% of flowCommon StockSEC:0001209191-23-050874:0
14,000 shares@ US$5.042.8% of flowCommon StockSEC:0001209191-23-008072:0
28,000 shares@ US$5.045.6% of flowCommon StockSEC:0001209191-23-004127:0
14,000 shares@ US$4.122.5% of flowCommon StockSEC:0001209191-22-056427:0
14,000 shares@ US$4.122.6% of flowCommon StockSEC:0001209191-22-053597:0
14,000 shares@ US$4.122.5% of flowCommon StockSEC:0001209191-22-050182:0
814 shares@ US$14.240.5% of flowCommon StockSEC:0001209191-22-041639:0
28,000 shares@ US$4.120.0046% mcap87.5% of flowCommon StockSEC:0001209191-22-024487:0
658 shares@ US$26.100.0006% mcap12.5% of flowCommon StockSEC:0001209191-22-002465:0
658 shares@ US$26.100.7% of flowCommon StockSEC:0001209191-22-002465
19 of 19 declarations
About Patel Sanjiv
Sanjiv Patel is the President and CEO at Relay Therapeutics, Inc. In this role, he is responsible for the strategic direction of the company and the implementation of growth initiatives. With extensive experience in the biopharmaceutical sector, Sanjiv focuses on optimizing the company's performance and creating value for shareholders. His leadership is essential for navigating a constantly evolving economic environment.
